METTL1 and glioma: In addition, we assessed whether METTL1 is a potential independent prognostic risk factor in gliomas by using a nomogram model. The purpose of this study was to explore the expression of METTL1 in glioma, its effect on the prognosis of patients, and to elucidate the potential molecular mechanism.